Brexit slows European drug agency work with 30% staff loss


About a third of employees at the European Union’s drug regulator are expected to quit as it leaves Britain because of Brexit, prompting the agency to temporarily scale back operations to focus on essential public health activities.

Liz Cohen comments on staff losses on the Bloomberg website.

Liz Cohen


Related Articles